Diet and Exercise as Essential Complements Adopting a balanced diet is crucial when taking Semaglutide
News provided by Scripta Insights May 20, 2025, 08:00 ET New member app feature delivers trusted, clinician-backed guidance as millions face GLP-1 access setbacks after CVS Caremark drops Zepbound and WeightWatchers files for bankruptcy BOSTON, May 20, 2025 /PRNewswire/ -- Scripta Insights , the doctor-driven, AI-powered pharmacy navigation company that guides self-insured employers, health plans and their members to prescription savings, announces today its GLP-1 Navigator , a new resource in the Scripta member app that gives patients up-to-date, trusted information about GLP-1 medications in a centralized guide
This distinction matters because GLP-1 medications were studied in populations with baseline excess adipose tissue, not in lean individuals
Preclinical studies show bone-protective, cardioprotective, and nephroprotective effects beyond GH release